The Biden administration should reverse “harmful Trump administration policies” that “undermined the 340B program and contravened Congress’ intent,” the group America’s Essential Hospitals advised President Biden in a letter earlier this month.
America’s Essential Hospitals’ Feb. 10 letter said the U.S. Health Resources and Services Administration (HRSA) should “act swiftly to put an end” to several drug manufacturers’ cessation of 340B pricing on drugs dispensed by contract pharmacies or imposition of conditions on such pricing.
The Biden administration should reverse “harmful Trump administration policies” that “undermined the 340B program and contravened Congress’ intent,” the group America’s Essential Hospitals advised President Biden in a letter earlier this month.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
